In this time of dire need, Sepragen team is doing its part to solve the problem of COVID-19. We are providing equipment on an expedited basis to a company developing a vaccine for COVID- 19.
Sepragen ships Custom Chromatography Systems

Sepragen ships Custom Chromatography Systems

Sepragen ships two, 125 LPM Custom Chromatography Systems with inline integrated Buffer Blending Capability for Covid-19 vaccine production in 14 weeks to enable ramp from 40M doses to 200M doses/ month.

Date
September 2020
share
news
You may also like
Browse All
May 2021
Sepragen wins NIIMBL grant
In the creation of bio-pharmaceutical drugs, cells are genetically modified to produce some compound shown by research to have a desired effect in a treatment program.
Learn more
January 2021
Sepragen wins NIIMBL award
Sepragen’s products or tools are used to manufacture over 24 FDA approved drugs including Kogenate®, Alphanate®, Neupogen®, and GammaGrand®* along with a multitude...
Learn more
September 2019
Sepragen partners with I&L Biosystems
Sepragen has pioneered the three patented processes for the isolation of high value nutritionals on a commercial scale. The Sepralac® Process enables the isolation of Lactoferrin...
Learn more
Sepragen, the original inventors of radial flow chromatography, is dedicated to supplying powerful, innovative tools and technologies which enable our customers to develop and manufacture life-saving biological drugs, vaccines and diagnostics quickly and cost-effectively.

©2026 - Sepragen Corporation - All right reserved

Contacts